-
Beijing Unveils Action Plan to Boost Pharmaceutical and Health Industry by 2026
•
The Beijing People’s Government has issued an “Action Plan” outlining measures and targets to “Accelerate Collaborative Innovation in Medicine and Health” over a three-year period from 2024 to 2026. Many of these measures were previously outlined in a draft document reported in April 2024. The plan sets an ambitious goal…
-
NHSA Unveils 2024 Medical Procurement Overhaul, Aiming for Synergy Between National and Provincial Levels
•
The National Healthcare Security Administration (NHSA) has issued a notification detailing plans to enhance the medical centralized procurement process in 2024. The goals include strengthening local procurement alliances and achieving a coordinated procurement strategy between national and local levels. For the national volume-based procurement (VBP), new batches will be led…
-
China’s Health Authorities Investigate Alleged Price Manipulation in Pharma Procurement Tenders
•
Chinese health regulators are delving into allegations of irregular pricing practices during the national volume-based procurement (VBP) tenders for several pharmaceutical products. A joint statement issued by the National Drug Alliance Procurement Office and the Shanghai Pharmaceutical Centralized Bidding Procurement Management Office cited public complaints regarding the bidding and pricing…
